Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23
Open accessAbstract
Phosphorylation of the p53 tumor suppressor at Ser20 (murine Ser23) has been proposed to be critical for disrupting p53 interaction with its negative regulator, MDM2, and allowing p53 stabilization. To determine the importance of Ser23 for the function of p53 in vivo, we generated a mouse in which the endogenous p53 locus was targeted to replace Ser23 with alanine. We show that, in mouse embryonic fibroblasts generated from Ser23 mutant mice, Ser23 mutation did not dramatically reduce IR-induced p53 protein stabilization or p53-dependent cell cycle arrest. However, in Ser23 mutant thymocytes and in the developing cerebellum, p53 stabilization following IR was decreased and resistance to apoptosis was observed. Homozygous Ser23 mutant animals had a reduced lifespan, but did not develop thymic lymphomas or sarcomas that are characteristic of p53-/- mice. Instead, Ser23 mutant animals died between 1 and 2 years with tumors that were most commonly of B-cell lineage. These data support an important role for Ser20/23 phosphorylation in p53 stabilization, apoptosis and tumor suppression.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mouse studies show that blocking p53 phosphorylation at corresponding serine residues only caused modest defects in p53-mediated apoptosis and tumor suppression function.
“Moreover, mouse studies show that blocking p53 phosphorylation at corresponding serine residues only caused modest defects in p53-mediated apoptosis and tumor suppression function [70–73].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [71]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693 · see citing works
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649 · see citing works
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · see citing works
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · see citing works
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047 · see citing works
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864 · see citing works
Self-citationThymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271 · see citing works
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206 · see citing works
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113 · see citing works
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · see citing works
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051 · see citing works
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042 · see citing works
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797 · see citing works
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,447 · see citing works
Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase
Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322 · see citing works
The complexity of p53 modulation: emerging patterns from divergent signalsPreprint
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,303 · see citing works
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y., Matsuoka, S., Wakeham, A. C., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,288 · see citing works
Radiation-induced cell cycle arrest compromised by p21 deficiency
Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., & Hannon, G. J. (1995) · Nature · doi:10.1038/377552a0 · Cited by 1,242 · cited 1× · see citing works
“Furthermore, p53 was fully functional in its ability to induce expression of p21 and MDM2 (Figure 2B). p53 null MEFs are resistant to a G1 arrest in response to gamma irradiation (Kastan et al, 1992), and this effect is in large part mediated by p21 (Brugarolas et al, 1995; Deng et al, 1995).”
BackgroundPost‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,071 · see citing works
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972 · see citing works
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M. L., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 899 · see citing works
DNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · see citing works
Chk2/hCds1 functions as a DNA damage checkpoint in G<sub>1</sub>by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805 · see citing works
Self-citationPhosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.
Chehab, N. H., Malikzay, A., Stavridi, E. S., & Halazonetis, T. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13777 · Cited by 583 · see citing works
Dumaz, N., & Meek, D. W. (1999) · The EMBO Journal · doi:10.1093/emboj/18.24.7002 · Cited by 455 · see citing works
Regulation of p53 function and stability by phosphorylation.
Ashcroft, M., Kubbutat, M. H. G., & Vousden, K. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1751 · Cited by 452 · see citing works
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
Takai, H., Naka, K., Okada, Y., Watanabe, M., Harada, N., Saito, S., Anderson, C. W., Appella, E., Nakanishi, M., Suzuki, H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf506 · Cited by 435 · see citing works
Herzog, K., Chong, M. J., Kapsetaki, M., Morgan, J. I., & McKinnon, P. J. (1998) · Science · doi:10.1126/science.280.5366.1089 · Cited by 417 · see citing works
Hirao, A., Cheung, A., Duncan, G. S., Girard, P.-M., Elia, A., Wakeham, A. C., Okada, H., Sarkissian, T., Wong, J. A., Sakai, T., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6521-6532.2002 · Cited by 404 · see citing works
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2
Unger, T., Juven‐Gershon, T., Moallem, E., Berger, M., Sionov, R. V., Lozano, G., Oren, M., & Haupt, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1805 · Cited by 365 · see citing works
Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1
Melchionna, R., Chen, X., Blasina, A., & McGowan, C. H. (2000) · Nature Cell Biology · doi:10.1038/35036406 · Cited by 307 · see citing works
Shieh, S.-Y., Taya, Y., & Prives, C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1815 · Cited by 299 · see citing works
Effects of genetic background on tumorigenesis in <i>p53</i>‐deficient mice
Donehower, L. A., Harvey, M., Vogel, H., McArthur, M. J., Montgomery, C. A., Park, S. H., Thompson, T., Ford, R. J., & Bradley, A. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140105 · Cited by 252 · see citing works
Mutations in serines 15 and 20 of human p53 impair its apoptotic activity
Unger, T., Sionov, R. V., Moallem, E., Yee, C., Howley, P. M., Oren, M., & Haupt, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1202656 · Cited by 190 · see citing works
Production and analysis of chimeric mice
Bradley, A. (1987) · Cited by 174 · see citing works
Involvement of wild-type p53 in pre-B-cell differentiation in vitro.
Shaulsky, G., Goldfinger, N., Peled, A., & Rotter, V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8982 · Cited by 160 · see citing works
The Chk2 Tumor Suppressor Is Not Required for p53 Responses in Human Cancer Cells
Jallepalli, P. V., Lengauer, C., Vogelstein, B., & Bunz, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213159200 · Cited by 154 · see citing works
Phosphorylation of Serine 18 Regulates Distinct p53 Functions in Mice
Sluss, H. K., Armata, H., Gallant, J., & Jones, S. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.976-984.2004 · Cited by 152 · see citing works
DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation
Blattner, C., Tobiasch, E., Litfen, M., Rahmsdorf, H. J., & Herrlich, P. (1999) · Oncogene · doi:10.1038/sj.onc.1202480 · Cited by 151 · see citing works
Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses
Chao, C., Hergenhahn, M., Kaeser, M. D., Wu, Z., Saito, S., Iggo, R., Hollstein, M., Appella, E., & Xu, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306938200 · Cited by 141 · see citing works
Xie, S., Wang, Q., Wu, H., Cogswell, J. P., Luo, L., Jhanwar‐Uniyal, M., & Dai, W. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104157200 · Cited by 137 · see citing works
Different impact of p53 and p21 on the radiation response of mouse tissues
Komarova, E. A., Christov, K. T., Faerman, A., & Gudkov, A. V. (2000) · Oncogene · doi:10.1038/sj.onc.1203717 · Cited by 124 · see citing works
Increased Sensitivity to UV Radiation in Mice with a p53 Point Mutation at Ser389
Bruins, W., Zwart, E., Attardi, L. D., Iwakuma, T., Hoogervorst, E. M., Beems, R. B., Miranda, B., van Oostrom, C. T. M., van den Berg, J., van den Aardweg, G. J., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.20.8884-8894.2004 · Cited by 121 · see citing works
Self-citationAloni-Grinstein, R., Schwartz, D., & Rotter, V. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07125.x · Cited by 105 · see citing works
Mutation of Mouse p53 Ser23 and the Response to DNA Damage
Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103 · see citing works
Dumaz, N., Milne, D., Jardine, L., & Meek, D. W. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590459 · Cited by 75 · see citing works
Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice.
Ward, J. M., Taddesse-Heath, L., Perkins, S. N., Chattopadhyay, S. K., Hursting, S. D., & Morse, H. C. (1999) · PubMed · Cited by 47 · see citing works
Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice.
Shick, L., Carman, J., Choi, J. K., Somasundaram, K., Burrell, M., De, H., Zeng, Y., Wang, Y., Wiman, K. G., Salhany, K., et al. (1997) · PubMed · Cited by 17 · see citing works
Flagged first, then by citations
1 of the 49 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610 · see citing works
Regulating the p53 pathway: in vitro hypotheses, in vivo veritas
Toledo, F., & Wahl, G. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2012 · Cited by 1,286 · see citing works
Tumour suppression by p53: a role for the DNA damage response?
Meek, D. W. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2716 · Cited by 604 · see citing works
Posttranslational Modification of p53: Cooperative Integrators of FunctionPreprint
Meek, D. W., & Anderson, C. W. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000950 · Cited by 487 · see citing works
The p53 orchestra: Mdm2 and Mdmx set the tone
Wade, M., Wang, Y. V., & Wahl, G. M. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.01.009 · Cited by 450 · see citing works
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449 · see citing works
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392 · see citing works
Regulation of the p53 response and its relationship to cancer
Meek, D. W. (2015) · Biochemical Journal · doi:10.1042/bj20150517 · Cited by 291 · see citing works
Zhao, Y., Lu, S., Wu, L., Chai, G., Wang, H., Chen, Y., Sun, J. T., Yu, Y., Zhou, W., Zheng, Q., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2782-2790.2006 · Cited by 277 · see citing works
Mechanism of p53 stabilization by ATM after DNA damage
Cheng, Q., & Chen, J. (2010) · Cell Cycle · doi:10.4161/cc.9.3.10556 · Cited by 248 · see citing works
Stracker, T. H., Usui, T., & Petrini, J. H. J. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.012 · Cited by 245 · see citing works
p53 alterations in human cancer: more questions than answers
Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 232 · see citing works
Olsson, A., Manzl, C., Strasser, A., & Villunger, A. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402196 · Cited by 200 · see citing works
20 years studying p53 functions in genetically engineered mice
Donehower, L. A., & Lozano, G. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2731 · Cited by 193 · see citing works
p53-dependent Induction of PVT1 and miR-1204
Barsotti, A. M., Beckerman, R., Laptenko, O., Huppi, K. E., Caplen, N. J., & Prives, C. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.322875 · Cited by 186 · see citing works
Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies
Xu-Monette, Z. Y., Medeiros, L. J., Li, Y., Orlowski, R. Z., Andreeff, M., Bueso-Ramos, C., Greiner, T. C., McDonnell, T. J., & Young, K. H. (2012) · Blood · doi:10.1182/blood-2011-11-366062 · Cited by 181 · see citing works
The role of ubiquitin modification in the regulation of p53
Hock, A. K., & Vousden, K. H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.022 · Cited by 168 · see citing works
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity
Cheng, Q., Chen, L., Li, Z., Lane, W. S., & Chen, J. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.294 · Cited by 165 · see citing works
Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression
Chao, C., Herr, D., Chun, J., & Xu, Y. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601167 · Cited by 158 · see citing works
MacLaine, N. J., & Hupp, T. R. (2009) · Aging · doi:10.18632/aging.100047 · Cited by 129 · see citing works
The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
Pant, V., Quintás-Cardama, A., & Lozano, G. (2012) · Blood · doi:10.1182/blood-2012-05-356014 · Cited by 129 · see citing works
New insights into p53 activation
Brooks, C. L., & Gu, W. J. (2010) · Cell Research · doi:10.1038/cr.2010.53 · Cited by 127 · see citing works
p53 N-terminal phosphorylation: a defining layer of complex regulation
Jenkins, L. M. M., Durell, S. R., Mazur, S. J., & Appella, E. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs145 · Cited by 119 · see citing works
Evidence for the Direct Binding of Phosphorylated p53 to Sites of DNA Breaks In vivo
Rashid, S. T. A., Dellaire, G., Cuddihy, A. R., Jalali, F., Vaid, M., Coackley, C. L., Folkard, M., Xu, Y., Chen, B. P. C., Chen, D. J., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0729 · Cited by 107 · see citing works
p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis
Kawase, T., Ichikawa, H., Ohta, T., Nozaki, N., Tashiro, F., Ohki, R., & Taya, Y. (2008) · Oncogene · doi:10.1038/onc.2008.32 · Cited by 105 · see citing works
Mouse Models of p53 FunctionsPreprint
Lozano, G. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001115 · Cited by 94 · see citing works
Rokudai, S., Aikawa, Y., Tagata, Y., Tsuchida, N., Taya, Y., & Kitabayashi, I. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805101200 · Cited by 89 · see citing works
In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models
Brož, D. K., & Attardi, L. D. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp331 · Cited by 89 · see citing works
Stommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 87 · see citing works
Regulation of Mutant p53 Protein Expression
Vijayakumaran, R., Tan, K. H., Miranda, P. J., Haupt, S., & Haupt, Y. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00284 · Cited by 87 · see citing works
What have animal models taught us about the p53 pathway?
Lozano, G., & Zambetti, G. P. (2005) · The Journal of Pathology · doi:10.1002/path.1704 · Cited by 76 · see citing works
Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
Nguyen, T., Menéndez, D., Resnick, M. A., & Anderson, C. W. (2014) · Human Mutation · doi:10.1002/humu.22506 · Cited by 74 · see citing works
Cell and tissue responses to genotoxic stress
Coates, P. J., Lorimore, S. A., & Wright, E. G. (2005) · The Journal of Pathology · doi:10.1002/path.1701 · Cited by 76 · see citing works
Mitochondrially Targeted p53 Has Tumor Suppressor Activities In vivo
Talos, F., Petrenko, O., Mena, P., & Moll, U. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1084 · Cited by 74 · see citing works
Regulation of MDM2 E3 Ligase Activity by Phosphorylation after DNA Damage
Cheng, Q., Cross, B. L., Li, B., Chen, L., Li, Z., & Chen, J. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05553-11 · Cited by 73 · see citing works
Hyperproliferation, cancer, and inflammation in mice expressing a Δ133p53-like isoform
Slatter, T. L., Hung, N. A., Campbell, H. G., Rubio, C., Mehta, R., Renshaw, P., Williams, G., Wilson, M., Engelmann, A., Jeffs, A. R., et al. (2011) · Blood · doi:10.1182/blood-2010-11-321851 · Cited by 72 · see citing works
Inhibition of p53 DNA Binding Function by the MDM2 Protein Acidic Domain
Cross, B. L., Chen, L., Cheng, Q., Li, B., Yuan, Z.-M., & Chen, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228981 · Cited by 69 · see citing works
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis
Carr, M. I., & Jones, S. N. (2016) · Translational Cancer Research · doi:10.21037/tcr.2016.11.75 · Cited by 70 · see citing works
The Ataxia Telangiectasia–Mutated Target Site Ser18 Is Required for p53-Mediated Tumor Suppression
Armata, H. L., Garlick, D. S., & Sluss, H. K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1610 · Cited by 68 · see citing works
Chk2 Suppresses the Oncogenic Potential of DNA Replication-Associated DNA Damage
Stracker, T. H., Couto, S. S., Cordon‐Cardo, C., Matos, T., & Petrini, J. H. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.028 · Cited by 64 · see citing works
p53–RNA interactions: New clues in an old mystery
Riley, K. J.-L., & Maher, L. J. (2007) · RNA · doi:10.1261/rna.673407 · Cited by 65 · see citing works
Wijnhoven, S., Zwart, E., Speksnijder, E. N., Beems, R. B., Olive, K. P., Tuveson, D. A., Jonkers, J., Schaap, M. M., van den Berg, J., Jacks, T., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1650 · Cited by 64 · see citing works
Toledo, F., Lee, C. J., Krummel, K. A., Rodewald, L.-W., Liu, C.-W., & Wahl, G. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00999-06 · Cited by 64 · see citing works
miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia
Nucera, S., Giustacchini, A., Boccalatte, F. E., Calabria, A., Fanciullo, C., Plati, T., Ranghetti, A., García-Manteiga, J. M., Cittaro, D., Benedicenti, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.007 · Cited by 64 · see citing works
Crippling p53 activities via knock-in mutations in mouse models
Iwakuma, T., & Lozano, G. (2007) · Oncogene · doi:10.1038/sj.onc.1210278 · Cited by 63 · see citing works
Liu, L., Cao, J., Zhao, J., Li, X., Suo, Z., & Li, H. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s226851 · Cited by 61 · see citing works
Ohki, R., Kawase, T., Ohta, T., Ichikawa, H., & Taya, Y. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00375.x · Cited by 60 · see citing works
Falcicchio, M., Ward, J. A., Macip, S., & Doveston, R. G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00362-3 · Cited by 58 · see citing works
Illuminating p53 function in cancer with genetically engineered mouse models
Garcia, P. B., & Attardi, L. D. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2013.12.014 · Cited by 59 · see citing works
Cooperative functions of Chk1 and Chk2 reduce tumour susceptibility in vivo
Niida, H., Murata, K., Shimada, M., Ogawa, K., Ohta, K., Suzuki, K., Fujigaki, H., Khaw, A. K., Banerjee, B., Hande, M. P., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.218 · Cited by 56 · see citing works
Craig, A. L., Chrystal, J. A., Fraser, J. A., Sphyris, N., Lin, Y., Harrison, B. J., Scott, M. T., Dornreiter, I., & Hupp, T. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-06 · Cited by 52 · see citing works
MDM2 Chaperones the p53 Tumor Suppressor
Wawrzynów, B., Żylicz, M., Wallace, M., Hupp, T. R., & Żylicz, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702767200 · Cited by 53 · see citing works
Extended String Binding Mode of the Phosphorylated Transactivation Domain of Tumor Suppressor p53
Okuda, M., & Nishimura, Y. (2014) · Journal of the American Chemical Society · doi:10.1021/ja506351f · Cited by 52 · see citing works
MacLaine, N. J., Øster, B., Bundgaard, B. B., Fraser, J. A., Buckner, C., Lazo, P. A., Meek, D. W., Höllsberg, P., & Hupp, T. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804433200 · Cited by 44 · see citing works
p53-mediated apoptosis prevents the accumulation of progenitor B cells and B-cell tumors
Slatter, T. L., Ganesan, P. L., Holzhauer, C., Mehta, R., Rubio‐Terres, C., Williams, G., Wilson, M., Royds, J. A., Baird, M. A., & Braithwaite, A. W. (2009) · Cell Death and Differentiation · doi:10.1038/cdd.2009.136 · Cited by 41 · see citing works
Amano, T., Nakamizo, A., Mishra, S. K., Gumin, J., Shinojima, N., Sawaya, R. A., & Lang, F. F. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9844-1 · Cited by 38 · see citing works
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 38 · see citing works
Mouse bites dogma: how mouse models are changing our views of how P53 is regulated in vivo
Wahl, G. M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401911 · Cited by 37 · see citing works
New insights into oncogenic stress
Haigis, K. M., & Sweet-Cordero, A. (2011) · Nature Genetics · doi:10.1038/ng0311-177 · Cited by 36 · see citing works
Lin, Y., Stevens, C., & Hupp, T. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611559200 · Cited by 36 · see citing works
Zinc induces ERK-dependent cell death through a specific Ras isoform
Klein, C., Creach, K. M., Irintcheva, V., Hughes, K. J., Blackwell, P. L., Corbett, J. A., & Baldassare, J. J. (2006) · APOPTOSIS · doi:10.1007/s10495-006-0089-6 · Cited by 36 · see citing works
Correction: Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation
Tang, J., Agrawal, T., Cheng, Q., Qu, L., Brewer, M. D., Chen, J., & Yang, X. (2013) · PLoS ONE · doi:10.1371/annotation/032b026d-5bcf-4c1b-aa15-65c226a53818 · Cited by 36 · see citing works
The p53-Mdm2 Loop: A Critical Juncture of Stress Response
Levav-Cohen, Y., Goldberg, Z., Tan, K. H., Alsheich-Bartok, O., Zuckerman, V., Haupt, S., & Haupt, Y. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_9 · Cited by 36 · see citing works
SMG7 is a critical regulator of p53 stability and function in DNA damage stress response
Luo, H., Cowen, L. E., Yu, G., Jiang, W. G., & Tang, Y. (2016) · Cell Discovery · doi:10.1038/celldisc.2015.42 · Cited by 33 · see citing works
Hoogervorst, E. M., Bruins, W., Zwart, E., van Oostrom, C. T. M., van den Aardweg, G. J., Beems, R. B., van den Berg, J., Jacks, T., STEEG, H. V., & de Vries, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4328 · Cited by 34 · see citing works
The roles of MDM2 and MDMX phosphorylation in stress signaling to p53
Chen, J. (2012) · Genes & Cancer · doi:10.1177/1947601912454733 · Cited by 33 · see citing works
Phosphorylation of Thr18 and Ser20 of p53 in Ad-p53–induced apoptosis
Nakamizo, A., Amano, T., Zhang, W., Zhang, X.-Q., Ramdas, L., Liu, T.-J., Bekele, B. N., Shono, T., Sasaki, T., Benedict, W. F., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-015 · Cited by 32 · see citing works
Naderi, E. H., Jochemsen, A. G., Blomhoff, H. K., & Naderi, S. (2011) · Neoplasia · doi:10.1593/neo.11542 · Cited by 31 · see citing works
Phosphorylation of Daxx by ATM contributes to DNA damage-induced p53 activation.
Tang, J., Agrawal, T., Cheng, Q., Qu, L., Brewer, M. D., Chen, J., & Yang, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055813 · Cited by 28 · see citing works
Insights into Wild-Type and Mutant p53 Functions Provided by Genetically Engineered Mice
Donehower, L. A. (2014) · Human Mutation · doi:10.1002/humu.22507 · Cited by 29 · see citing works
A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal
Fraser, J. A., Madhumalar, A., Blackburn, E. A., Bramham, J., Walkinshaw, M. D., Verma, C. S., & Hupp, T. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143107 · Cited by 28 · see citing works
A Novel p53 Phosphorylation Site within the MDM2 Ubiquitination Signal
Fraser, J. A., Vojtěšek, B., & Hupp, T. R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143099 · Cited by 28 · see citing works
Češková, P., Chichger, H., Wallace, M., Vojtesek, B., & Hupp, T. R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.12.026 · Cited by 27 · see citing works
Role of Specific B-Cell Receptor Antigens in Lymphomagenesis
Thurner, L., Hartmann, S., Neumann, F., Hoth, M., Stilgenbauer, S., Küppers, R., Preuss, K., & Bewarder, M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.604685 · Cited by 25 · see citing works
Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene
Dudgeon, C., Kek, C., Demidov, O. N., Saito, S., Fernandes, K., Diot, A., Bourdon, J., Lane, D. P., Appella, E., Fornace, A. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2063 · Cited by 25 · see citing works
Finlan, L. E., Nenutil, R., Ibbotson, S. H., Vojtesek, B., & Hupp, T. R. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3393 · Cited by 25 · see citing works
Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx
Lu, Z., Wan, G., Guo, H., Zhang, X., & Lu, X. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.12.014 · Cited by 24 · see citing works
Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo
Slee, E. A., Benassi, B., Goldin, R. D., Zhong, S., Ratnayaka, I., Blandino, G., & Lü, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005165107 · Cited by 24 · see citing works
Tp53 deletion in B lineage cells predisposes mice to lymphomas with oncogenic translocations
Rowh, M. A. W., DeMicco, A., Horowitz, J. E., Yin, B., Yang-Iott, K. S., Fusello, A. M., Hobeika, E., Reth, M. G., & Bassing, C. H. (2011) · Oncogene · doi:10.1038/onc.2011.191 · Cited by 24 · see citing works
The Changing Face of HDAC Inhibitor Depsipeptide
Zhou, W., & Zhu, W. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314039 · Cited by 23 · see citing works
The phenotype of MDM2 auto-degradation after DNA damage is due to epitope masking by phosphorylation
Cheng, Q., & Chen, J. (2011) · Cell Cycle · doi:10.4161/cc.10.7.15249 · Cited by 21 · see citing works
The role of the ubiquitin proteasome system in lymphoma
Suh, K. S., Tanaka, T., Sarojini, S., Nightingale, G., Gharbaran, R., Pecora, A. L., & Goy, A. H. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.02.005 · Cited by 20 · see citing works
Øster, B., Bundgaard, B. B., Hupp, T. R., & Höllsberg, P. (2007) · Journal of General Virology · doi:10.1099/vir.0.83136-0 · Cited by 20 · see citing works
Serine 312 phosphorylation is dispensable for wild-type p53 functions in vivo
Lee, M. K., Tong, W., Wang, Z. Q., & Sabapathy, K. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.90 · Cited by 17 · see citing works
van Kesteren, P. C. E., Beems, R. B., Luijten, M., Robinson, J. F., de Vries, A., & STEEG, H. V. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp013 · Cited by 14 · see citing works
Bruins, W., Jonker, M. J., Bruning, O., Pennings, J. L. A., Schaap, M. M., Hoogervorst, E. M., STEEG, H. V., Breit, T. M., & de Vries, A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm041 · Cited by 13 · see citing works
Modeling the Study of DNA Damage Responses in Mice
Specks, J., Nieto-Soler, M., Lopez-Contreras, A. J., & Fernández-Capetillo, Ó. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2297-0_21 · Cited by 13 · see citing works
Defining relative mutational difficulty to understand cancer formation
Shan, L., Yu, J., He, Z., Chen, S., Liu, M., Ding, H., Xu, L., Zhao, J., Yang, A. E., & Jiang, H. (2020) · Cell Discovery · doi:10.1038/s41421-020-0177-8 · Cited by 12 · see citing works
Induction of B-cell lymphoma by UVB Radiation in p53 Haploinsufficient Mice
Puebla‐Osorio, N., Miyahara, Y., Sreevidya, C. S., Limón-Flores, A. Y., Kazimi, N., Ullrich, S. E., & Zhu, C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-36 · Cited by 11 · see citing works
Requirement for phosphorylation of P53 at Ser312 in suppression of chemical carcinogenesis
Slee, E. A., & Lü, X. (2013) · Scientific Reports · doi:10.1038/srep03105 · Cited by 10 · see citing works
Multienzyme assembly of a p53 transcription complex
Hupp, T. R., & Walkinshaw, M. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1007-885 · Cited by 8 · see citing works
Marney, C. B., Anderson, E. S., Baum, R., & Schmitt, A. M. (2022) · Cells · doi:10.3390/cells11111818 · Cited by 7 · see citing works
El-Dahr, S. S., Aboudehen, K., & Dipp, S. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90378.2008 · Cited by 7 · see citing works
Huang, H.-S., Chu, S., Chen, P., Lee, M., Huang, C.-Y., Chou, H.-M., & Chu, T. (2021) · Journal of Cancer · doi:10.7150/jca.60120 · Cited by 6 · see citing works
Lee, M. K., & Sabapathy, K. (2007) · Neoplasia · doi:10.1593/neo.07511 · Cited by 6 · see citing works
Mis-splicing drives loss of function of p53E224D point mutation
Lock, I. C., Leisenring, N. H., Floyd, W., Xu, E. S., Luo, L., Ma, Y., Mansell, E. C., Cardona, D. M., Lee, C., & Kirsch, D. G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0318856 · Cited by 4 · see citing works
Dynamics of Delayed p53 Mutations in Mice Given Whole-Body Irradiation at 8 Weeks
Okazaki, R., Ootsuyama, A., Kakihara, H., Mabuchi, Y., Matsuzaki, Y., Michikawa, Y., Imai, T., & Norimura, T. (2010) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.07.022 · Cited by 4 · see citing works
DNA Damage Signaling Downstream of ATM
Bunz, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-8044-1_2 · Cited by 3 · see citing works
Characterization of the E3 Ubiquitin Ligase Pirh2
Tai, E. (2010) · TSpace (University of Toronto) · Cited by 3 · see citing works
Regulation of p53 Activity and Associated Checkpoint Controls
Post, S. M., Quintás‐Cardama, A., & Lozano, G. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-178-3_11 · Cited by 2 · see citing works
- Authors
- MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Venere, M., Halazonetis, T. D., Bronson, R., de Vries, A., Fleming, M., & Jacks, T.
- Affiliations
- Center for Cancer Research (US)
- Sogang University (KR)
- Massachusetts Institute of Technology (US)
- The Wistar Institute (US)
- Tufts University (US)
- Boston Children's Hospital (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Jacks, Tyler
- ORCID
- Venue
- The EMBO Journal
- Published
- 2004-09-02
- Volume
- 23
- Issue
- 18
- Pages
- 3689-3699
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC517606
- OpenAlex
- W2158689768
- Cited by
- 124
- References
- 49
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 2 · 2018: 1 · 2016: 3 · 2015: 4 · 2014: 8 · 2013: 8 · 2012: 6
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- The EMBO Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rivm (National Institute for Public Health and the Environment) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- University of Pennsylvania
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, p53 stabilization, apoptosis resistance, B-cell lymphoma, thymocytes, cerebellar development, tumor suppression, mouse model, ionizing radiation, lifespan
- MeSH terms
- Animals, Cell Cycle, Cells, Cultured, Cerebellum, DNA Damage, Female, Fibroblasts, Homozygote, Infrared Rays, Male, Mice, Inbred C57BL, Phosphorylation, Serine, Thymus Gland, Survival Rate, Tumor Suppressor Protein p53, Lymphoma, B-Cell, Apoptosis, Point Mutation, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
